Comparison of Drugs in the Metastatic and Adjuvant Settings

This study found a substantial difference in the number of agents available for use in the metastatic and adjuvant settings for non-small cell lung cancer, breast cancer, and colon cancer.

Source: CancerNetwork - April 25, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news